-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WQ4dbh1e5uxMIwIWLWtyx+O7n2soqAJj/XJbGNs4ADMNMOLktjB5VjbyOocu5+Do WIMBA5S3Gy0p8Yh+NpnGVQ== 0000830736-01-500021.txt : 20010710 0000830736-01-500021.hdr.sgml : 20010710 ACCESSION NUMBER: 0000830736-01-500021 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20010705 ITEM INFORMATION: FILED AS OF DATE: 20010706 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XTRANA INC CENTRAL INDEX KEY: 0000830736 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 581729436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-14257 FILM NUMBER: 1675731 BUSINESS ADDRESS: STREET 1: 370 INTERLOCKEN BLVD CITY: BROOMFIELD STATE: CO ZIP: 80021 BUSINESS PHONE: 8056540643 MAIL ADDRESS: STREET 1: 370 INTERLOCKEN BLVD CITY: BROOMFIELD STATE: CO ZIP: 80021 FORMER COMPANY: FORMER CONFORMED NAME: BIOPOOL INTERNATIONAL INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: CYTRX BIOPOOL LTD DATE OF NAME CHANGE: 19890716 8-K 1 form8k070501.txt CURRENT REPORT ON FORM 8-K DATED JULY 5, 2001 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------------- Form 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 5, 2001 XTRANA, INC. (FORMERLY BIOPOOL INTERNATIONAL, INC.) (Exact Name of Registrant as Specified in Charter) Delaware 0-17714 58-1729436 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 370 Interlocken Blvd. Broomfield, Colorado 80021 (Address of Principal Executive Offices) (303) 474-2133 (Registrant's Telephone Number) 1 ITEM 5. OTHER EVENTS Reference is made to the press release of Xtrana, Inc., (formerly, Biopool International, Inc., the "Registrant"), issued on July 5, 2001, announcing that the Registrant has changed its name from Biopool International, Inc., to Xtrana, Inc. A copy of the press release, which contains information meeting the requirements of this Item 5, is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by this reference. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (a) Financial Statements. None. (b) Pro Forma Financial Information. None. (c) Exhibits. Exhibit 99.1 Press Release of the Registrant dated July 5, 2001, announcing that the Registrant has changed its name from Biopool International, Inc., to Xtrana, Inc. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. July 5, 2001 XTRANA, INC. By: /S/ TIMOTHY DAHLTORP ----------------------------- Timothy Dahltorp Chief Executive Officer Chief Financial Officer 3 EXHIBIT INDEX EXHIBIT PAGE NUMBER 99.1 Press Release of the Registrant Dated 5 July 5, 2001, Announcing that the Registrant has Changed its Name from Biopool International, Inc., to Xtrana, Inc. 4 EX-99 2 exh99-070501.txt EXHIBIT 99.1 - PRESS RELEASE DATED 7/5/01 EXHIBIT 99.1 THURSDAY JULY 5, 13:43 EASTERN TIME PRESS RELEASE BIOPOOL INTERNATIONAL BECOMES XTRANA, INC. DENVER, Colorado (July 5, 2001) - Xtrana, Inc. (OTCBB:BIPL) today announced that the Company has changed its name from Biopool International, Inc., to Xtrana, Inc. The name change was approved by the Company's stockholders at its Annual Meeting held June 21, 2001. An Amended and Restated Certificate of Incorporation of Biopool International, Inc., changing the corporate name to Xtrana, Inc., was filed pursuant to the General Corporation Law of the State of Delaware June 22, 2001. Effective July 6, 2001, the Company's Common Stock, which currently trades on the OTC Bulletin Board(R) under the symbol BIPL, will trade under the new trading symbol XTRN. Timothy J. Dahltorp, the Company's chief executive officer, commented, "Using the corporate name Xtrana is more conducive to our current business strategies and mission, and has been contemplated since the merger itself. Operating under both the Biopool International and Xtrana brand names over the past year has created some level of confusion in the marketplace as to the Company's identity. Changing our name to Xtrana, Inc., clearly communicates our commitment to the development and commercialization of nucleic acid based diagnostics. We will, however, leverage off of the well-established Biopool brand name by continuing to sell our clinical diagnostic products under this trade name." Xtrana, Inc., develops, manufactures, and markets a full range of test kits to assess and diagnose disorders of blood coagulation, thrombotic risk factors, fibrinolysis, platelet function, and the vascular system. Effective with the Company's merger in August 2000, the Company also develops nucleic acid-based tests for use in drug discovery, detection of environmental and food contaminants, forensics, and identity testing, human and animal diseases, genetic predisposition to disease, and other applications. To learn more about Xtrana, visit the Company's new website at www.xtrana.com. NOTE: This press release contains forward-looking statements, which are based upon current expectations that involve a number of risks and uncertainties including, but not limited to, technological innovations of competitors, changes in health care regulations, litigation claims, foreign currency fluctuation, product acceptance or changes in government regulation of the Company's products, as well as other factors discussed in the Company's last Report on Form 10-KSB under "Risk Factors." Contact: Biopool International Inc./Xtrana Timothy Dahltorp, 303/474-2133 Carol Hill, 805/654-0643 5 -----END PRIVACY-ENHANCED MESSAGE-----